Medicure Inc. Files 6-K with Financial Results
Ticker: MCUJF · Form: 6-K · Filed: May 29, 2024 · CIK: 1133519
| Field | Detail |
|---|---|
| Company | Medicure Inc (MCUJF) |
| Form Type | 6-K |
| Filed Date | May 29, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-results, 6-K, reporting
TL;DR
Medicure Inc. dropped their 6-K with financial results on 5/28.
AI Summary
On May 28, 2024, Medicure Inc. filed a Form 6-K report. The filing includes a news release announcing their financial results. Dr. Albert D. Friesen, CEO, signed the report.
Why It Matters
This filing provides investors with an update on Medicure Inc.'s financial performance, which can influence investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial reporting filing (6-K) and does not contain significant new risks.
Key Players & Entities
- Medicure Inc. (company) — Registrant
- Dr. Albert D. Friesen (person) — CEO and signatory
- May 28, 2024 (date) — Filing date
FAQ
What type of report is Medicure Inc. filing?
Medicure Inc. is filing a Form 6-K report, which is a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
When was this report filed?
This report was filed on May 29, 2024, and pertains to the month of May 2024, with a date as of May 28, 2024.
Who is the CEO of Medicure Inc. and did they sign the report?
Yes, Dr. Albert D. Friesen is the CEO of Medicure Inc. and signed the report on behalf of the company on May 28, 2024.
What is the primary exhibit included in this 6-K filing?
The primary exhibit included in this 6-K filing is Exhibit 99.1, which is a News Release announcing financial results.
Where is Medicure Inc. headquartered?
Medicure Inc. is headquartered in Winnipeg, Manitoba, Canada, with its principal executive offices located at 2-1250 Waverley Street, Winnipeg, MB Canada R3T 6C6.
Filing Stats: 145 words · 1 min read · ~1 pages · Grade level 8.1 · Accepted 2024-05-29 10:39:29
Filing Documents
- med_6k.htm (6-K) — 10KB
- med_ex991.htm (EX-99.1) — 130KB
- med_ex991img2.jpg (GRAPHIC) — 3KB
- 0001654954-24-007002.txt ( ) — 145KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Medicure Inc. (Registrant) Date: May 28, 2024 By: /s/ Dr. Albert D. Friesen Dr. Albert D. Friesen Title: CEO 3